These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 21629130

  • 1. Variable cardiac 18FDG patterns seen in oncologic positron emission tomography computed tomography: importance for differentiating normal physiology from cardiac and paracardiac disease.
    Maurer AH, Burshteyn M, Adler LP, Gaughan JP, Steiner RM.
    J Thorac Imaging; 2012 Jul; 27(4):263-8. PubMed ID: 21629130
    [Abstract] [Full Text] [Related]

  • 2. How to differentiate benign versus malignant cardiac and paracardiac 18F FDG uptake at oncologic PET/CT.
    Maurer AH, Burshteyn M, Adler LP, Steiner RM.
    Radiographics; 2011 Jul; 31(5):1287-305. PubMed ID: 21918045
    [Abstract] [Full Text] [Related]

  • 3. Comprehensive Oncologic Imaging in Infants and Preschool Children With Substantially Reduced Radiation Exposure Using Combined Simultaneous ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging: A Direct Comparison to ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
    Gatidis S, Schmidt H, Gücke B, Bezrukov I, Seitz G, Ebinger M, Reimold M, Pfannenberg CA, Nikolaou K, Schwenzer NF, Schäfer JF.
    Invest Radiol; 2016 Jan; 51(1):7-14. PubMed ID: 26309185
    [Abstract] [Full Text] [Related]

  • 4. 18F-FDG PET/CT findings of radiotherapy-related myocardial changes in patients with thoracic malignancies.
    Unal K, Unlu M, Akdemir O, Akmansu M.
    Nucl Med Commun; 2013 Sep; 34(9):855-9. PubMed ID: 23728520
    [Abstract] [Full Text] [Related]

  • 5. Spatial and temporal heterogeneity of regional myocardial uptake in patients without heart disease under fasting conditions on repeated whole-body 18F-FDG PET/CT.
    Inglese E, Leva L, Matheoud R, Sacchetti G, Secco C, Gandolfo P, Brambilla M, Sambuceti G.
    J Nucl Med; 2007 Oct; 48(10):1662-9. PubMed ID: 17873124
    [Abstract] [Full Text] [Related]

  • 6. Fluorodeoxyglucose positron emission tomography with computed tomography detects greater metabolic changes that are not represented by plain radiography for patients with osteonecrosis of the jaw.
    Fleisher KE, Raad RA, Rakheja R, Gupta V, Chan KC, Friedman KP, Mourtzikos KA, Janal M, Glickman RS.
    J Oral Maxillofac Surg; 2014 Oct; 72(10):1957-65. PubMed ID: 25053572
    [Abstract] [Full Text] [Related]

  • 7. Imaging of oncologic patients: benefit of combined CT and FDG PET in the diagnosis of malignancy.
    Eubank WB, Mankoff DA, Schmiedl UP, Winter TC, Fisher ER, Olshen AB, Graham MM, Eary JF.
    AJR Am J Roentgenol; 1998 Oct; 171(4):1103-10. PubMed ID: 9763005
    [Abstract] [Full Text] [Related]

  • 8. Benign variations and incidental abnormalities of myocardial FDG uptake in the fasting state as encountered during routine oncology positron emission tomography studies.
    Fukuchi K, Ohta H, Matsumura K, Ishida Y.
    Br J Radiol; 2007 Jan; 80(949):3-11. PubMed ID: 17005513
    [Abstract] [Full Text] [Related]

  • 9. The utility of 18F-fluorodeoxyglucose positron emission tomography for early diagnosis of radiation-induced myocardial damage.
    Jingu K, Kaneta T, Nemoto K, Ichinose A, Oikawa M, Takai Y, Ogawa Y, Nakata E, Sakayauchi T, Takai K, Sugawara T, Narazaki K, Fukuda H, Takahashi S, Yamada S.
    Int J Radiat Oncol Biol Phys; 2006 Nov 01; 66(3):845-51. PubMed ID: 17011456
    [Abstract] [Full Text] [Related]

  • 10. Multifactorial relationship between 18F-fluoro-deoxy-glucose positron emission tomography signaling and biomechanical properties in unruptured aortic aneurysms.
    Nchimi A, Cheramy-Bien JP, Gasser TC, Namur G, Gomez P, Seidel L, Albert A, Defraigne JO, Labropoulos N, Sakalihasan N.
    Circ Cardiovasc Imaging; 2014 Jan 01; 7(1):82-91. PubMed ID: 24190906
    [Abstract] [Full Text] [Related]

  • 11. The relevance of 18F-fluorodeoxyglucose positron emission tomography/computed tomography imaging in diagnosing prosthetic graft infections post cardiac and proximal thoracic aortic surgery.
    Guenther SP, Cyran CC, Rominger A, Saam T, Kazmierzcak PM, Bagaev E, Pichlmaier M, Hagl C, Khaladj N.
    Interact Cardiovasc Thorac Surg; 2015 Oct 01; 21(4):450-8. PubMed ID: 26174118
    [Abstract] [Full Text] [Related]

  • 12. Potential pitfalls in interpretation of positron emission tomography/computed tomography findings in the thorax.
    Carter BW, Betancourt SL, Viswanathan C, Mawlawi O, Marom EM, Truong MT.
    Semin Roentgenol; 2015 Jul 01; 50(3):210-6. PubMed ID: 26002241
    [No Abstract] [Full Text] [Related]

  • 13. Role of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in the characterization of pancreatic masses: experience from tropics.
    Santhosh S, Mittal BR, Bhasin D, Srinivasan R, Rana S, Das A, Nada R, Bhattacharya A, Gupta R, Kapoor R.
    J Gastroenterol Hepatol; 2013 Feb 01; 28(2):255-61. PubMed ID: 23278193
    [Abstract] [Full Text] [Related]

  • 14. PET/CT quantitation of the effect of patient-related factors on cardiac 18F-FDG uptake.
    Israel O, Weiler-Sagie M, Rispler S, Bar-Shalom R, Frenkel A, Keidar Z, Bar-Shalev A, Strauss HW.
    J Nucl Med; 2007 Feb 01; 48(2):234-9. PubMed ID: 17268020
    [Abstract] [Full Text] [Related]

  • 15. Can 3'-Deoxy-3'-((18)F) Fluorothymidine Out Perform 2-Deoxy-2-((18)F) Fluoro-D-Glucose Positron Emission Tomography/Computed Tomography in the Diagnosis of Cervical Lymphadenopathy in Patients With Oral/Head and Neck Cancer?
    Schaefferkoetter JD, Carlson ER, Heidel RE.
    J Oral Maxillofac Surg; 2015 Jul 01; 73(7):1420-8. PubMed ID: 25869746
    [Abstract] [Full Text] [Related]

  • 16. Thorax: normal and benign pathologic patterns in FDG-PET/CT imaging.
    Wachsmann JW, Gerbaudo VH.
    PET Clin; 2014 Apr 01; 9(2):147-68. PubMed ID: 25030279
    [Abstract] [Full Text] [Related]

  • 17. Clinical implication of myocardial FDG uptake pattern in oncologic PET: retrospective comparison study with stress myocardial perfusion imaging as the reference standard.
    Takanami K, Saito M, Matsumoto Y, Sugimura K, Takase K.
    Ann Nucl Med; 2020 Apr 01; 34(4):233-243. PubMed ID: 31981092
    [Abstract] [Full Text] [Related]

  • 18. 18F-FDG PET/CT imaging of multiple myxofibrosarcoma in left upper abdomen and chest wall.
    Yi C, Wang X, Shi X, Zhang X, Chen Z.
    Nuklearmedizin; 2012 Apr 01; 51(6):N53-4. PubMed ID: 23250511
    [No Abstract] [Full Text] [Related]

  • 19. Head and neck: normal variations and benign findings in FDG positron emission tomography/computed tomography imaging.
    Højgaard L, Berthelsen AK, Loft A.
    PET Clin; 2014 Apr 01; 9(2):141-5. PubMed ID: 25030278
    [Abstract] [Full Text] [Related]

  • 20. Assessment of [(18)F]-fluoroacetate PET/CT as a tumor-imaging modality: preclinical study in healthy volunteers and clinical evaluation in patients with liver tumor.
    Takemoto K, Hatano E, Nishii R, Kagawa S, Kishibe Y, Takahashi M, Yamauchi H, Matsumura K, Zaima M, Toriguchi K, Tanabe K, Kitamura K, Seo S, Taura K, Endo K, Uemoto S, Higashi T.
    Ann Nucl Med; 2014 May 01; 28(4):371-80. PubMed ID: 24599824
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.